Undisclosed EGFR/B7H3 CAR-T
/ Guangzhou Bio-gene Technology, Guangzhou Medical University
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
June 25, 2024
EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer
(clinicaltrials.gov)
- P1 | N=30 | Recruiting | Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Trial completion date: May 2025 ➔ May 2035 | Trial primary completion date: May 2025 ➔ May 2030
Metastases • Trial completion date • Trial primary completion date • Breast Cancer • Lung Cancer • Oncology • Solid Tumor • Triple Negative Breast Cancer • CD276 • EGFR
April 22, 2022
EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer
(clinicaltrials.gov)
- P1 | N=30 | Recruiting | Sponsor: Second Affiliated Hospital of Guangzhou Medical University
New P1 trial • Breast Cancer • Lung Cancer • Oncology • Solid Tumor • Triple Negative Breast Cancer • CD276 • EGFR
1 to 2
Of
2
Go to page
1